Literature DB >> 22898541

Retroviral oncogenes: a historical primer.

Peter K Vogt1.   

Abstract

Retroviruses are the original source of oncogenes. The discovery and characterization of these genes was made possible by the introduction of quantitative cell biological and molecular techniques for the study of tumour viruses. Key features of all retroviral oncogenes were first identified in src, the oncogene of Rous sarcoma virus. These include non-involvement in viral replication, coding for a single protein and cellular origin. The MYC, RAS and ERBB oncogenes quickly followed SRC, and these together with PI3K are now recognized as crucial driving forces in human cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22898541      PMCID: PMC3428493          DOI: 10.1038/nrc3320

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  191 in total

1.  Common modifications of trimeric G proteins and ras protein: involvement of polyisoprenylation.

Authors:  A A Finegold; W R Schafer; J Rine; M Whiteway; F Tamanoi
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

2.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

Review 3.  Oncogenes in retroviruses and cells: biochemistry and molecular genetics.

Authors:  K Bister; H W Jansen
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

Review 4.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

5.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

6.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

7.  Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

Authors:  R Dalla-Favera; E P Gelmann; S Martinotti; G Franchini; T S Papas; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein.

Authors:  R M Kris; I Lax; W Gullick; M D Waterfield; A Ullrich; M Fridkin; J Schlessinger
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

9.  PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.

Authors:  Maria-Magdalena Georgescu
Journal:  Genes Cancer       Date:  2010-12

Review 10.  Potential therapeutic strategies to overcome acquired resistance to BRAF or MEK inhibitors in BRAF mutant cancers.

Authors:  Ryan B Corcoran; Jeffrey Settleman; Jeffrey A Engelman
Journal:  Oncotarget       Date:  2011-04
View more
  46 in total

1.  Discovery of oncogenes: The advent of molecular cancer research.

Authors:  Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

2.  Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90.

Authors:  Edgar E Boczek; Lasse G Reefschläger; Marco Dehling; Tobias J Struller; Elisabeth Häusler; Andreas Seidl; Ville R I Kaila; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

3.  Identification of ALV-J associated acutely transforming virus Fu-J carrying complete v-fps oncogene.

Authors:  Yixin Wang; Jianliang Li; Yang Li; Lichun Fang; Xiaolong Sun; Shuang Chang; Peng Zhao; Zhizhong Cui
Journal:  Virus Genes       Date:  2016-04-25       Impact factor: 2.332

Review 4.  Listening to each other: Infectious disease and cancer immunology.

Authors:  Russell E Vance; Michael J Eichberg; Daniel A Portnoy; David H Raulet
Journal:  Sci Immunol       Date:  2017-01-13

5.  Stopping MYC in its tracks.

Authors:  Eduard Stefan; Jonathan R Hart; Klaus Bister
Journal:  Aging (Albany NY)       Date:  2015-07       Impact factor: 5.682

Review 6.  Metabolic reprogramming: a hallmark of viral oncogenesis.

Authors:  P Lévy; B Bartosch
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

7.  The Activation of c-Src Tyrosine Kinase: Conformational Transition Pathway and Free Energy Landscape.

Authors:  Mikolai Fajer; Yilin Meng; Benoît Roux
Journal:  J Phys Chem B       Date:  2016-10-28       Impact factor: 2.991

Review 8.  Long story short: p53 mediates innate immunity.

Authors:  Jessica Miciak; Fred Bunz
Journal:  Biochim Biophys Acta       Date:  2016-03-04

Review 9.  Dephosphorylating eukaryotic RNA polymerase II.

Authors:  Joshua E Mayfield; Nathaniel T Burkholder; Yan Jessie Zhang
Journal:  Biochim Biophys Acta       Date:  2016-01-15

10.  Human oncogenic viruses: nature and discovery.

Authors:  Yuan Chang; Patrick S Moore; Robin A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.